$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
艾曲波帕重度再生障碍性贫血患者一线治疗
2025-10-19 11:44:20
Check Details
艾曲波帕治疗血小板减少的安全性
2025-10-19 11:44:20
Check Details
艾曲波帕可降低血小板减少患者的出血率
2025-10-19 11:44:20
Check Details
艾曲波帕联合标准的免疫疗法治疗SAA患者
2025-10-19 11:44:20
Check Details
艾曲波帕慢性ITP患者的特效药
2025-10-19 11:44:20
Check Details
慢性丙型肝炎血小板减少症患者可以服用艾曲波帕
2025-10-19 11:44:20
Check Details
艾曲波帕治疗特发性血小板减少症紫癜的的药效
2025-10-19 11:44:20
Check Details
艾曲波帕在慢性复发或难治特发性血小板减少性紫癜的疗效
2025-10-19 11:44:20
Check Details
艾曲波帕在继发于丙型肝炎病毒相关性肝硬化的血小板减少的疗效
2025-10-19 11:44:20
Check Details
食物和抗酸剂对艾曲波帕吸收的影响
2025-10-19 11:44:20
Check Details
艾曲波帕是一种酶诱导剂或拟制剂
2025-10-19 11:44:20
Check Details
艾曲波帕在化疗所致的血小板减少症的疗效
2025-10-19 11:44:20
Check Details
1
2
...
836
837
838
839
840
841
842
...
935
936
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Belumosudil for Chronic Graft-Versus-Host Disease (cGVHD): Efficacy, Side Effects, and Patient Treatment Guide
2
Olutasidenib: Mechanism of Action and Clinical Guide for IDH1-Mutated AML
3
Gilteritinib: Efficacy, Medication Guide and Latest Advances for FLT3-Mutated AML
4
Common Adverse Reactions and Clinical Safety Management of Gilteritinib (Xospata)
5
Adverse Reaction Profile and Clinical Safety Management of Idelalisib
6
Clinical Significance of Platelet Recovery During Revumenib (Menin Inhibitor) Therapy
7
A Key Therapeutic Breakthrough Against T315I-Mutant CML
8
Tafasitamab: An Fc-Enhanced CD19-Targeted Immunotherapy for B-Cell Malignancies
9
Tafasitamab and Lenalidomide Combination Therapy Guide
10
Pirtobrutinib (Jaypirca) Medication Guide: Overcoming BTK Resistance & Safety Management
11
Gilteritinib Professional Medication Guide & Dosage Management
12
Pirtobrutinib: A Novel Non-Covalent BTK Inhibitor for Relapsed Hematologic Malignancies